Capital Investment Counsel, Inc Medtronic PLC Transaction History

Capital Investment Counsel, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$78.22 - $90.4 $11,733 - $13,560	-150 Reduced 5.5%	2,577 $201,000
Q1 2023 Apr 27, 2023	BUY	$76.72 - $87.58 $7,672 - $8,758	100 Added 3.81%	2,727 $219,000
Q4 2022 Jan 31, 2023	BUY	$76.18 - $87.74 $200,124 - $230,492	2,627 New	2,627 $204,000
Q2 2022 Jul 22, 2022	BUY	$87.4 - $113.09 $5,418 - $7,011	62 Added 2.33%	2,727 $245,000
Q1 2022 May 02, 2022	BUY	$100.58 - $112.38 $268,045 - $299,492	2,665 New	2,665 $296,000
Q4 2020 Feb 11, 2021	SELL	$100.57 - $117.14 $326,852 - $380,705	-3,250 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$90.13 - $108.78 $54,078 - $65,268	600 Added 22.64%	3,250 $338,000
Q2 2020 Aug 04, 2020	BUY	$84.11 - $103.33 $222,891 - $273,824	2,650 New	2,650 $243,000
Q4 2019 Jan 29, 2020	SELL	$104.49 - $114.54 $1.12 Million - $1.23 Million	-10,746 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$98.02 - $111.18 $1.05 Million - $1.19 Million	10,746 New	10,746 $119,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Counsel, Inc with notifications on news.